BCL2 and neoplasm: In vivo experiments demonstrated a superior effectiveness of the combinatorial approach PSPG/DOX/Bcl-2 when compared to PSPG/DOX or PSPG/Bcl-2 alone, with no increase in tumor volume after 22 days of treatment and no side effects.